2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Réeff J et al. Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. 2015 Int J Pharm pmid:25934426
Borgheti-Cardoso LN et al. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. 2015 Eur J Pharm Sci pmid:25917525
Murgia S et al. Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. 2015 Colloids Surf B Biointerfaces pmid:25829131
Tyler AI et al. Electrostatic swelling of bicontinuous cubic lipid phases. 2015 Soft Matter pmid:25790335
Oka T Transformation between inverse bicontinuous cubic phases of a lipid from diamond to primitive. 2015 Langmuir pmid:25719417
Sintov AC Transdermal delivery of curcumin via microemulsion. 2015 Int J Pharm pmid:25655717
Tisor O et al. Adaptability of monoglyceride-induced crystallization of K2SO4: effect of various anions and lipid chain splay. 2015 Langmuir pmid:25645981
Zhang Y et al. Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel. 2015 Int J Pharm pmid:25543112
Li JC et al. Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol. 2015 Med. Sci. Monit. pmid:26517086
Montis C et al. Magnetocubosomes for the delivery and controlled release of therapeutics. 2015 J Colloid Interface Sci pmid:25533536
Elnaggar YS et al. Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies. 2015 Int J Nanomedicine pmid:26346130
Carneiro C et al. DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. 2015 Eur J Pharm Biopharm pmid:25499956
Peng X et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. 2015 Drug Des Devel Ther pmid:26345516
Liang YL et al. Uptake of the butyrate receptors, GPR41 and GPR43, in lipidic bicontinuous cubic phases suitable for in meso crystallization. 2015 J Colloid Interface Sci pmid:25490566
Reese CW et al. Structural insights into the cubic-hexagonal phase transition kinetics of monoolein modulated by sucrose solutions. 2015 Phys Chem Chem Phys pmid:25758637
Milak S and Zimmer A Glycerol monooleate liquid crystalline phases used in drug delivery systems. 2015 Int J Pharm pmid:25479099
Rachmawati H et al. Curcumin nanoemulsion for transdermal application: formulation and evaluation. 2015 Drug Dev Ind Pharm pmid:24502271
Shan-Bin G et al. Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation. 2015 Drug Dev Ind Pharm pmid:24502270
Adwan S et al. Glyceryl monooleate-based otic delivery system of ofloxacin: release profile and bactericidal activity. 2015 Pharm Dev Technol pmid:24392877
Sallam AS et al. Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel. 2015 Pharm Dev Technol pmid:24262092